ClinConnect ClinConnect Logo
Search / Trial NCT02560883

Hairy Cell Leukemia Patient Data Registry

Launched by OHIO STATE UNIVERSITY COMPREHENSIVE CANCER CENTER · Sep 24, 2015

Trial Information

Current as of July 01, 2025

Recruiting

Keywords

Hairy Cell

ClinConnect Summary

The Hairy Cell Leukemia Patient Data Registry is a study aimed at gathering important information about hairy cell leukemia, a rare type of blood cancer that affects adults. With around 1,000 new cases diagnosed in the U.S. each year, this registry will help researchers better understand the disease, find out which treatments work best, identify any new complications, and design future clinical trials for new therapies. By collecting data from patients, the goal is to ultimately improve the quality of life for those living with this condition.

To participate in this study, patients must be adults diagnosed with either classic hairy cell leukemia or its variant. Unfortunately, children cannot participate since this disease typically doesn’t occur in younger individuals. Those who join the registry can expect to provide information about their health and experiences, which will be used to help advance research and improve care for future patients. This project is currently recruiting participants, and anyone interested should talk to their healthcare provider about eligibility and how they can get involved.

Gender

ALL

Eligibility criteria

  • Inclusion:
  • Patients with classic hairy cell leukemia
  • Patients with the variant of hairy cell leukemia.
  • Exclusion:
  • Children are excluded from the study, since Hairy Cell Leukemia wasn't described in children.

About Ohio State University Comprehensive Cancer Center

The Ohio State University Comprehensive Cancer Center (OSUCCC) is a leading institution dedicated to advancing cancer research, treatment, and education. As a National Cancer Institute-designated comprehensive cancer center, OSUCCC integrates cutting-edge research with clinical practice to develop innovative therapies and improve patient outcomes. With a collaborative approach that unites scientists and clinicians, OSUCCC focuses on personalized medicine, cancer prevention, and community outreach, striving to enhance the understanding of cancer biology and provide hope to patients through groundbreaking clinical trials and comprehensive care programs.

Locations

Rochester, Minnesota, United States

Columbus, Ohio, United States

Winnipeg, Manitoba, Canada

Miami, Florida, United States

Rochester, New York, United States

Melbourne, Victoria, Australia

Patients applied

0 patients applied

Trial Officials

Michael Grever, MD

Principal Investigator

The Ohio State University Comprehensive Cancer Center

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials